About: High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 1997 (uk) im Juni 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 1997 (ast) scientific article published on 01 June 1997 (en)
publication date	wds:Q73478176-C736E71F-1B28-40F2-B51A-905FD6AA10AC
publication date	1997-06-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q73478176-E8F77131-2A08-476F-B44A-1EC10050A911
exact match	https://scigraph.springernature.com/pub.10.1038/sj.bmt.1700820
cites work	wds:Q73478176-D6C70B4C-48A6-4E0D-8752-22C2C5267469
cites work	High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial
author name string	wds:Q73478176-051718A0-8CD8-4AA7-9639-646365662192 wds:Q73478176-0AFAF4E3-82DF-4562-87FF-C0B67E227E56 wds:Q73478176-1C7009A2-52AB-4BBD-A194-80E946CDC33E wds:Q73478176-1EBFE6B8-5D08-4544-B86B-F8D9E27FAD5A wds:Q73478176-2AB8BD1B-151E-412F-9E7F-9A82FCC3C68E wds:Q73478176-32EFF03E-5068-49A3-BFC5-B820FAA108AD wds:Q73478176-3A8C10A3-03E0-47C8-A09C-5815DD9AEAEC wds:Q73478176-450FEA2E-2933-444A-AA6D-C6DE39C68C69 wds:Q73478176-527967A2-13D2-41AD-8CCA-32EE80536D4A wds:Q73478176-5A55D70A-BAFD-4388-B58E-637901AC9A54 wds:Q73478176-617DA98D-868B-4237-9553-476D7E5A70B6 wds:Q73478176-A589295F-176A-43DD-A180-F35C40D53205 wds:Q73478176-A714F5E5-FD24-45C6-AEDA-C992E92E4234 wds:Q73478176-B7FB6F01-B7CC-4131-9083-117AE9D5F52F wds:Q73478176-D1295829-90FA-4063-997D-5FA80925B80E wds:Q73478176-FA369215-94F0-4B58-AEEE-8FF4CDE2686C
author name string	P Montgomery L Holmberg W I Bensinger E Ellis S Rowley P Weiden K Lilleby C H Weaver R McCroskey R Maziarz W Nichols S Rivkin J P Klarnet S Petersdorf A Hertler K S Schiffman
rdfs:label	High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer (en) High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer (nl)
skos:prefLabel	High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer (en) High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer (nl)
name	High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer (en) High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer (nl)
author	wds:Q73478176-086286C7-C7AC-4362-8851-A760F9F09BCE wds:Q73478176-275F24EA-DB83-4912-B144-D1B4427CB6C2
author	Frederick R. Appelbaum C. Dean Buckner
title	wds:Q73478176-A6700DEC-5127-4C8E-8CB4-7F993359A1E2
title	High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer (en)
page(s)	wds:Q73478176-CD5A88E2-D467-43E7-B59D-4D45EFB7EB1E
page(s)	1183-1189
instance of	wds:Q73478176-1E472768-AD21-4881-A2C4-3160C734B39D
instance of	scholarly article
main subject	wds:Q73478176-8C438FD1-87F5-45AC-AD41-8AF1C7DBA4F5
main subject	metastatic breast cancer
PubMed ID	wds:Q73478176-ABE0DCC4-E90A-4065-ACBC-46A1FF74E558
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9208111
PubMed ID	9208111
published in	wds:Q73478176-833622B8-6DC7-433B-AD3D-7999A5229720
published in	Bone Marrow Transplantation
issue	wds:Q73478176-4082A048-4E07-46EA-84BF-59FF4C5E7E55
volume	wds:Q73478176-BEA35E17-0E08-4FCE-A0E0-8C337F6DF8FA
issue	12
volume	19
DOI	wds:Q73478176-B15D9C01-5C1F-47D4-BAF0-022004779757
DOI	http://dx.doi.org/10.1038/SJ.BMT.1700820
DOI	10.1038/SJ.BMT.1700820
Dimensions Publication ID	wds:Q73478176-0CB6F693-A3F8-4EAF-A4BA-78662C07875C
Dimensions Publication ID	1020119689
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73478176
is cites work of	Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution. The role of busulfan in bone marrow transplantation Methodologic guidelines for the design of high-dose chemotherapy regimens High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34+ selection to clinical outcome A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch Excessive toxicity of once daily i.v. BU, melphalan and thiotepa followed by auto SCT on patients with non-Hodgkin's lymphoma Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors. Fatal upper and lower gastrointestinal cytomegalovirus disease following autologous peripheral blood stem cell transplantation Treatment of breast cancer with chemotherapy in combination with filgrastim: approaches to improving therapeutic outcome High-dose chemotherapy and autologous stem cell transplantation as treatment for high-risk breast cancer. Paclitaxel and Trastuzumab as Maintenance Therapy in Patients with HER2-Positive Metastatic Breast Cancer Who Underwent High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation Treatment of multiple myeloma High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer
is cites work of	wds:Q28374416-50F1326D-9F0F-40EF-8223-B73B4A89DE28 wds:Q44458205-DAED5BEF-BF84-459C-B006-3746E7AFB8DE wds:Q40371959-26033814-EAF2-4B5E-A891-8655F984B1EA wds:Q35024456-8324F398-C869-4893-9255-EBA1F142610D wds:Q54132013-2B698697-0E53-4CE8-B723-132300337E6D wds:Q33411110-DF1CC77A-BCF1-4555-830F-D385A15B39FC wds:Q35847414-C298E335-DD3B-47FE-A424-82C826D3F3BF

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software